Home' Australian Pharmacist : Australian Pharmacist May 2016 Contents Australian Pharmacist May 2016 I ©Pharmaceutical Society of Australia Ltd. 5
The PSA, as members would be aware, represents pharmacists from every
area of pharmacy practice and this can sometimes make for interesting
conversations when the PSA advocates in ways that appear to one particular
sector of the profession that the society is less committed to their particular
interests than they should be.
It is a delicate balancing act that I believe
PSA has been managing successfully over
many years and across all sectors of the
PSA has expressed its clear support for
Community Pharmacy as the biggest
single employer of pharmacists, and has
recognised the importance of the pharmacy
network as a vehicle to deliver 5,500
individual health destination locations
where pharmacists can deliver health
solutions to consumers.
We believe that at present there is no
better way for the PSA to support members
working in community pharmacies than to
assist pharmacy owners and pharmacists to
transition to a model of pharmacy practice
that provides health solutions that meet
local community needs.
This is why we have developed our Health
Destination Pharmacy model of practice.
But clearly community pharmacy is
not the only place where pharmacists
practice and as Australia's peak
organisation representing pharmacists,
the Pharmaceutical Society of Australia
is committed to improving the
sustainability and competitiveness of the
The PSA is advocating for new models
of practice for which there is strong
international and domestic evidence of
positive health impact and associated cost
savings, providing a robust rationale for
new investment and income streams.
For example, PSA has led the development
and implementation of the General Practice
Pharmacist model and the integration of
pharmacists in Aboriginal Health Services.
Immunisation delivered by pharmacists is
another clear example.
The model that PSA has proposed for
pharmacists in GP clinics is not only a
developing model of practice for pharmacists
in Australia, but is also a new and additional
model of practice for community pharmacy to
become involved in.
Based on existing models internationally,
the general practice pharmacist has an
important role in brokering relationships
between the general practice team,
patients and community pharmacies
and advocating for engagement with the
community pharmacy team.
It is a clear advantage to community
pharmacy to be more involved as an
integral member of the healthcare team,
and it is expected that the integration of a
pharmacist within the local general practice
setting would also result in the increased
uptake of 6CPA services through the local
community pharmacy. So the model is not
only good for patients and pharmacists, but
also good for community pharmacies.
To support this initiative PSA has introduced
its Pharmacy/GP Connect Program
which will link interested GP clinics with
a compatible pharmacist interested in
practising in this model.
Anyone interested should contact PSA now.
One profession --
BY JOE DEMARTE, FPS, NATIONAL PRESIDENT
NATIONAL PRESIDENT SAYS
We also understand that pharmacists are
clearly disillusioned with poor wages and
lack of career path options. The 2015 PSA
member survey clearly highlighted that
remuneration is the single largest challenge
facing the pharmacy profession.
Pharmacist wages have been in slow decline
-- and there is no single, quick-fix solution.
Incremental increases in the Pharmacy
Industry Award are important; however
a long-term solution for appropriate
remuneration across the profession is
The PSA is committed to a strategic, practical
plan to meet the future needs of consumers
and improve remuneration for pharmacists
and is presently completing its career path
options program to assist pharmacists to
achieve new career path opportunities as we
develop them and advocate for increased
funding for these roles
PSA has also taken a strong stance that
some pharmacist services should be funded
through alternate mechanisms, and has
continually advocated for pharmacists to be
included on the Medicare Benefits Schedule
(MBS) and be eligible for remuneration
through private health insurers. Long term,
we believe the GP pharmacist should be
funded through MBS.
In some cases, roles for pharmacists are
well-developed internationally, yet have not
progressed in Australia.
Australian consumers are missing out on
access to the full breadth of pharmacist
services, from prevention to assisting in
chronic disease management, that are
possible under current scope of practice.
PSA is working tirelessly to ensure that
the broader health system recognises
the contribution pharmacists can make
so that they are able to play a key role in
new and emerging models linked to wider
Government health reform objectives, such
as the patient-centred Health Care Home.
PSA is committed to ensuring that these
roles for pharmacists are fully realised
and supported through robust, evidence-
based advocacy, practical resources and
appropriate funding mechanisms.
PSA will also be supporting and fostering
innovation through linkages with both
industry and academia.
Links Archive Australian Pharmacist April 2016 Australian Pharmacist June 2016 Navigation Previous Page Next Page